protein intake optimization glp-1 receptor agonists Dietary by patients taking and dual GIP/GLP-1 agonists: A narrative review and discussion of research needs Application of nutrition interventions with
Description
is supported by the American Heart AssociationBristol Myers Squibb Foundation through the Winn Diversity in Clinical Trials Clinical Investigator Leadership Award, and by the National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Physician-Scientist Career Development Award, Grant Number K12DK133995 (David Maahs, Linda DiMeglio, Multi-Center Program Directors)

They will consider your unique health needs, lifestyle, and preferences, and guide you in making an informed decision about the most suitable weight management solution

Accessed April 2026

The SURMOUNT trials show consistently greater weight loss with tirzepatide compared to semaglutide, but also steeper regain after discontinuation

This makes it an ideal research tool for developing new drugs and studying metabolism

Information on Peptide Sciences retatrutide and bulk sourcing from China represents the current landscape for those in the research community
